Preimplantation genetic diagnosis and hereditary cancer
Full article: https://www.statnews.com/2017/10/23/ivf-embryo-genetic-testing/?utm_source=STAT+Newsletters&utm_campaign=6739b36bbd-MR&utm_medium=email&utm_term=0_8cab1d79
Andrew Joseph’s piece for STAT, “A baby with a disease gene or no baby at all: Genetic testing of embryos creates an ethical morass,” focuses on preimplantation genetic diagnosis (PGD) and the emerging ethical issue in the field of reproductive medicine: What to do when patients seeking to get pregnant select embryos with DNA that could lead to a disease or a disability. (11/8/17)
Questions To Ask Your Health Care Provider
- What are the key points to consider when balancing family planning with cancer risk reduction?
- I want to have children, what are my options for managing my risk for cancer?
- What are my options if I wish to undergo In Vitro Fertilization and Preimplantation Genetic Diagnosis?
- How does IVF and childbearing affect my risk for cancer?
- Will my insurance pay for IVF and PGD? Are there resources to help defray the costs?
Open Clinical Trials
The following research studies related to fertility preservation are enrolling patients.
Fertility preservation studies for women
Fertility preservation for men
- NCT02972801: Testicular Tissue Cryopreservation for Fertility Preservation. Testicular tissue cryopreservation is an experimental procedure involving testicular tissue that is retrieved and frozen. This technique is reserved for young male patients, with the ultimate goal that their tissue may be used in the future to restore fertility when experimental techniques emerge from the research pipeline.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.